Top

Marin Kollef, MD, FACP, FCCP, Chairman, is Professor of Medicine at the Washington University School of Medicine and Director of the Medical Intensive Care Unit and Respiratory Care Services at Barnes-Jewish Hospital in St. Louis, Missouri.

Paul G. Ambrose, PharmD, is President of the Institute for Clinical Pharmacodynamics, New York, USA; Honorary Research Fellow in Infectious Diseases at the University of Oxford, UK; and Adjunct Associate Research Professor at the University at Buffalo, New York. Dr. Ambrose is an editor for Antimicrobials Agents and Chemotherapy.

Philip S. Barie, MD, is Professor of Surgery at Weill Cornell Medical College and an attending surgeon at New York-Presbyterian/Weill Cornell Medical Center. He is also Chief, Preston A. Wade (Red) Acute Care Surgery Service, New York-Presbyterian Hospital, Weill Cornell Medical Center.

Helen W. Boucher, MD, is Director of the Infectious Diseases Fellowship Program and Ventricular Assist Device and Cardiac Transplant Infectious Diseases Program at Tufts Medical Center. She is an attending physician in the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center and Associate Professor of Medicine at Tufts University School of Medicine.

Jean Chastre, MD, is a Consulting Professor, Medical ICU, Hospital Pitié-Salpêtrière, Paris.

Ralph Corey, MD, is Professor of Medicine, Infectious Disease, and Pathology; Gary Hock Professor of Global Health; and Vice-Chairman of the Department of Medicine at Duke University.

Vance Fowler, MD, is Professor of Medicine and Professor in Molecular Genetics and Microbiology at Duke University.

Bruno Francois, MD, is Specialist, Intensive Care Medicine at University Hospital of Limoges, France. Dr. Francois is also Head of the Limoges Clinical Investigational Center.

Howard Mayer, MD, is Senior Vice President and Head of Global Clinical Development at Shire Pharmaceuticals.

Vandana Menon, MD, PhD, MPH, is Vice President, Better Outcomes Corporation and Adjunct Associate Professor, Tufts-New England Medical Center.

Debra Poutsiaka, MD, PhD, is Associate Professor of Medicine, Tufts University School of Medicine and an Attending Physician, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center.

George Sakoulas, MD, is Associate Adjunct Professor, Division of Host-Microbe Systems and Therapeutics, Center for Immunity, Infection, and Inflammation, at the University of California San Diego School of Medicine.

Joseph Solomkin, MD, is Professor of Surgery (Emeritus), University of Cincinnati College of Medicine and the CEO of OASIS Global.

George Talbot, MD, is a Member and Immediate past Co-Chair of the ABSSSI/CABP and HABP/VABP Project Teams at the Biomarkers Consortium of the Foundation of the National Institutes of Health. Dr. Talbot is a Principal at Talbot Advisors, LLC.

Antoni Torres, MD, PhD, is Head, Respiratory Intensive Care Unit, Department of Pneumology and Respiratory Allergy at the Clinical Institute of the Thorax, Hospital Clinic of Barcelona.